Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor ImmunityJuan J. Miret, Esra A. Akbay|Journal for ImmunoTherapy of Cancer|2019Cited by 152
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in miceEsra A. Akbay, Kwok‐Kin Wong|Genes & Development|2014Cited by 86
Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burdenMingrui Zhu, Esra A. Akbay|Cancer Cell|2023Cited by 52
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Esra A. Akbay, Mei Zheng|RePEc: Research Papers in Economics|2020Cited by 11